Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Pulmonary Hypertension

Free Subscription Articles published in Thorax Retrieve available abstracts of 19 articles: HTML format

Single Articles

December 2025
1. TAYLOR JC, Knowlton KU, Wilson TC, Dodson MW, et al
   Recurrent right atrial myxoma presenting as pulmonary hypertension and peripheral pulmonary artery aneurysms.
   Thorax. 2025 Dec 10:thorax-2025-223625. doi: 10.1136/thorax-2025-223625.
   PubMed    
   
   
   November 2025
2. BALASUBRAMANIAN A, Hemnes AR, Brittain EL, Annis J, et al
   Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD.
   Thorax. 2025 Nov 27:thorax-2025-223921. doi: 10.1136/thorax-2025-223921.
   PubMed     Abstract available
   
   
   June 2025
3. SONG Y, Li F, Xie W, Zhao L, et al
   Is it truly chronic thromboembolic pulmonary hypertension? A case of pulmonary hypertension with proptosis.
   Thorax. 2025 Jun 15:thorax-2024-222953. doi: 10.1136/thorax-2024-222953.
   PubMed    
   
   
   
4. NATHAN SD
   Early phase clinical trials in pulmonary hypertension: how small is big enough?
   Thorax. 2025 Jun 1:thorax-2025-223535. doi: 10.1136/thorax-2025-223535.
   PubMed    
   
   
   
5. CZEPIEL K, Nagy N, Panjalingam T, Kalinowski A, et al
   Randomised, placebo-controlled trial of oral hymecromone in adults with pulmonary hypertension.
   Thorax. 2025 Jun 1:thorax-2024-222725. doi: 10.1136/thorax-2024-222725.
   PubMed     Abstract available
   
   
   May 2025
6. KHOR YH, Palm A, Wong AW, Guler SA, et al
   Effects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study.
   Thorax. 2025;80:378-384.
   PubMed     Abstract available
   
   
   February 2025
7. KIKO T, Tsuji A, Ueda J, Ohta-Ogo K, et al
   Vasodilator-induced selective pulmonary oedema in sarcoidosis-associated pulmonary hypertension with pulmonary venous stenosis.
   Thorax. 2025 Feb 27:thorax-2024-222190. doi: 10.1136/thorax-2024-222190.
   PubMed    
   
   
   
8. ALSULAYYIM AS, Alasmari AM, Price LC, McCabe C, et al
   Dietary nitrate supplementation enhances exercise capacity in WHO Group 3 pulmonary hypertension: a double-blind, placebo-controlled, randomised crossover study (EDEN-OX2).
   Thorax. 2025 Feb 8:thorax-2024-222019. doi: 10.1136/thorax-2024-222019.
   PubMed     Abstract available
   
   
   October 2024
9. MIARD C, de Montpreville VT, Bernaudin JF, Adam J, et al
   Platelet aggregates in lung capillaries in severely decompensated pulmonary hypertension.
   Thorax. 2024 Oct 7:thorax-2024-222034. doi: 10.1136/thorax-2024-222034.
   PubMed     Abstract available
   
   
   April 2024
10. AGAOGLU ES, Semple T, Wells AU, Wort S, et al
    Unilateral pleural effusion with pulmonary hypertension in sarcoidosis: do not forget the pulmonary veins!
    Thorax. 2024 Apr 29:thorax-2023-220058. doi: 10.1136/thorax-2023-220058.
    PubMed    
    
    
    
11. CASSADY SJ, Maron BA
    Mildly elevated pulmonary vascular resistance and worsened survival in PH-ILD: an opportunity for earlier diagnosis and intervention?
    Thorax. 2024;79:387-388.
    PubMed    
    
    
    
12. SATO T, Furukawa T, Teramachi R, Fukihara J, et al
    Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease.
    Thorax. 2024;79:422-429.
    PubMed     Abstract available
    
    
    
13. GONG S, Li H, Wang L
    Pulmonary artery-pulmonary artery collaterals in chronic thromboembolic pulmonary hypertension.
    Thorax. 2024 Apr 10:thorax-2023-221219. doi: 10.1136/thorax-2023-221219.
    PubMed    
    
    
    March 2024
14. NATHAN SD, Johri S, Joly JM, King CS, et al
    Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality.
    Thorax. 2024;79:301-306.
    PubMed     Abstract available
    
    
    February 2024
15. PICCARI L, Wort SJ
    Use of inhaled treprostinil in patients with interstitial lung disease and pulmonary hypertension: to boldly go where no other pulmonary vasodilator has gone before?
    Thorax. 2024 Feb 2:thorax-2023-221167. doi: 10.1136/thorax-2023-221167.
    PubMed    
    
    
    November 2023
16. MARIN-ROMERO S, Ballaz-Quincoces A, Gomez-Cuervo C, Marchena-Yglesias PJ, et al
    Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study.
    Thorax. 2023 Nov 30:thorax-2023-220580. doi: 10.1136/thorax-2023-220580.
    PubMed     Abstract available
    
    
    
17. BARTNIK A, Pepke-Zaba J, Bunclark K, Ruggiero A, et al
    Cardiac MRI in the assessment of chronic thromboembolic pulmonary hypertension and response to treatment.
    Thorax. 2023 Nov 22:thorax-2022-219716. doi: 10.1136/thorax-2022-219716.
    PubMed    
    
    
    July 2023
18. MAI V, Gosselin C, Tremblay E, Rompre G, et al
    Patients' perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy.
    Thorax. 2023;78:721-725.
    PubMed     Abstract available
    
    
    January 2023
19. KING JA, Desai A, Semple T, Nicholson AG, et al
    Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension-management challenges.
    Thorax. 2023;78:107-109.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.